EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia-Reference-Cited by-同舟云学术

EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia

Author:

Chu Ming‐qiang¹,Zhang Ting‐juan²³⁴,Xu Zi‐jun³⁴⁵,Gu Yu²³⁴,Ma Ji‐chun³⁴⁵,Zhang Wei²³⁴,Wen Xiang‐mei³⁴⁵,Lin Jiang³⁴⁵,Qian Jun²³⁴,Zhou Jing‐dong²³⁴^ORCID

Affiliation:

1. Department of Respiratory Medicine Affiliated People’s Hospital of Jiangsu University Zhenjiang Jiangsu China

2. Department of Hematology Affiliated People’s Hospital of Jiangsu University Zhenjiang Jiangsu China

3. Zhenjiang Clinical Research Center of Hematology Zhenjiang Jiangsu China

4. The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City Zhenjiang Jiangsu China

5. Laboratory Center Affiliated People’s Hospital of Jiangsu University Zhenjiang Jiangsu China

Funder

National Natural Science Foundation of China-Yunnan Joint Fund

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

Reference35 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献